Carrasco D, Prieto M, Pallardó L, Moll J L, Cruz J M, Muñoz C, Berenguer J
J Hepatol. 1985;1(6):573-8. doi: 10.1016/s0168-8278(85)80001-5.
We report a case of multiple hepatic adenomas developed in a 32-year-old man with renal allograft after long-term therapy with testosterone enanthate. Histological assessment showed a benign hepatocellular adenoma, which has not regressed over a 6-month follow-up since androgen withdrawal. A review of primary hepatic tumors associated with androgenic-anabolic steroid therapy published in the English literature has been carried out, concentrating on the more relevant recent publications. No previous case of hepatic adenoma with possible relationship to the use of non-17-alpha alkylated compounds has been reported.
我们报告了一例32岁接受肾移植的男性在长期使用庚酸睾酮治疗后发生多发性肝腺瘤的病例。组织学评估显示为良性肝细胞腺瘤,自停用雄激素后6个月的随访中未见消退。我们对英文文献中发表的与雄激素-合成代谢类固醇治疗相关的原发性肝肿瘤进行了综述,重点关注了近期更相关的出版物。此前尚无关于可能与使用非17-α烷基化化合物有关的肝腺瘤病例报道。